Last reviewed · How we verify
NCT06666777: SPEAK
Speech Therapy and Parenting for Early Socio-communicAtive sKills
NA trial testing Intervention focused on intersubjective prelinguistic and socio-communicative skills in Neurological Impairments in 60 participants. Currently enrolling.
31 July 2026
Quick facts
| Lead sponsor | IRCCS Eugenio Medea |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 19 March 2025 |
| Primary completion | 31 July 2026 |
| Estimated completion | 1 September 2026 |
| Sites | 9 locations across Italy |
Drugs / interventions tested
- Intervention focused on intersubjective prelinguistic and socio-communicative skills
- Standard speech therapy intervention
Conditions studied
- Neurological Impairments — all drugs for Neurological Impairments →
- Genetic Syndrome — all drugs for Genetic Syndrome →
- Neurodevelopmental Disability — all drugs for Neurodevelopmental Disability →
- Developmental Delays — all drugs for Developmental Delays →
Sponsor
IRCCS Eugenio Medea — full company profile →
Who can join
Adults 6 Months to 59 Months, any sex, with Neurological Impairments or Genetic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Every year, millions of children are diagnosed with neurodevelopmental disabilities. This term covers a wide range of conditions, from genetic syndromes to brain injuries such as cerebral palsy. Children with neurodevelopmental disabilities often struggle in multiple areas, including language development. While standard speech therapy mainly focuses on understanding and producing words, these children may also have difficulties with the social and communicative skills needed for language. The parent-child relationship is especially important for helping kids develop in their early years. This clinical trial aims to find out if an intervention focused on early social and communication skills, and involving parents, can help children with neurodevelopmental disabilities. The study includes children aged 6 months to 5 years. It seeks to answer two key questions: * Does this intervention improve social and communication skills better than standard speech therapy? * Does this intervention affect how parents interact with their child? To find the answers, the study will compare two groups: one group will get the parent-involved intervention that focuses on early communication skills, while the other group will get standard speech therapy. In the first intervention, therapists will guide parents in observing and supporting their child's social and communication behaviors during various activities like playtime and snack time. In contrast, the standard speech therapy will focus on traditional goals, such as improving the child's ability to vocalize, understand, and use words, without involving parents. Both interventions will follow the same schedule-eight weekly sessions, each lasting 45 minutes, over two months. Before and after the interventions, the children and parents will: * Have an assessment of the child's language, social, and communication development. * Participate in a 10-minute video recording of parent-child playtime, which will be used to study parenting behavior.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Speech therapy and parenting for early socio-communicative skills in young children with neurodevelopmental disabilities (SPEAK): study protocol for an Italian multicentre randomised controlled trial.
Porro C, Butti N, Sacchi D, Rigamonti R, et al · · 2025 · PMID 41193214 · DOI 10.1136/bmjopen-2025-102104
Verify or expand the search:
- PubMed search for NCT06666777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other IRCCS Eugenio Medea trials
Trials by the same sponsor.
- NCT07095062 — Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome. · NA · recruiting
- NCT06993389 — AI-based Model for Rehabilitation Engagement and Motor Performance Evaluation in Pediatric Patients · recruiting
- NCT06999850 — Implementation and Validation of Instrumented Stair Climb Test · NA · recruiting
- NCT07470138 — Sleep Disturbance in Subjects With Autism Spectrum Disorders (ASD) in Preschool Age (18-60 Months) · recruiting
- NCT06710301 — Cortical Correlates of Spatial Navigation Skills in an Immersive Virtual Reality Environment · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06666777 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Eugenio Medea
- Last refreshed: 24 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06666777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing